Registry and Database Lap Prostatectomy
Laparoscopic Radical Prostatectomy: A Registry and Database
1 other identifier
observational
9
1 country
1
Brief Summary
Recently, many centers have begun offering laparoscopic radical prostatectomy (LRP) as a minimally invasive therapy for localized prostate cancer.1-6 LRP may offer the advantages of improved neurovascular bundle sparing, a more precise urethrovesical anastomosis, shorter hospitalization, and decreased convalescence. Our group at Methodist Urology, LLC has extensive experience in laparoscopy and in treating prostate cancer and are planning to offer LRP. We intend to maintain a registry and database to document the outcomes with LRP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2003
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 9, 2005
CompletedFirst Posted
Study publicly available on registry
September 15, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedJune 29, 2016
September 1, 2008
12.8 years
September 9, 2005
June 28, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To create a registry and database for the treatment of localized prostate cancer with LRP. To record long term outcomes for patients undergoing Laparoscopic Radical Prostatectomy.
One year
Study Arms (1)
cohort
Registry and Database
Interventions
Eligibility Criteria
Patients of Methodist Urology that are scheduled to undergo a laser procedure for prostate removal
You may qualify if:
- Patient of Methodist Urology in Indianapolis, IN
- Ability to give informed consent
- Biopsy proven diagnosis of prostate cancer without local extension or metastatic disease (Clinical T2 or less in the TNM classification)
You may not qualify if:
- Major abdominal surgery precluding a safe laparoscopic approach
- Bleeding diathesis or anticoagulation
- Medical disease (such as cardiovascular or pulmonary diseases) precluding general anesthesia/laparoscopy
- Transplanted kidney in the pelvis
- Radiation therapy to pelvis
- Morbid obesity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Methodist Hospital
Indianapolis, Indiana, 46202, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Larry Munch, MD
Methodist Urology, LLC
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 9, 2005
First Posted
September 15, 2005
Study Start
June 1, 2003
Primary Completion
April 1, 2016
Study Completion
April 1, 2016
Last Updated
June 29, 2016
Record last verified: 2008-09